← Loop Biotech Biotech

FDA data show companion diagnostics reshaped cancer drug development toward smaller trials

The analysis traces how biomarker tests enabled approvals based on smaller studies.

Read at Bioengineer.org →

fdadiagnosticsoncology

Full coverage · 2 outlets

Bioengineer.org · lead
MedicaldailyFDA Renamed and Updated Its Companion Diagnostics List, Including the First Test That Detects Cancer's Return in Blood